Jeevan Scientific Technology
add_icon

Jeevan Scientific Technology

77.01
-0.07
(-0.09%)
Market Cap
153.36 Cr
PE Ratio
148.23
Volume
2,167.00
Day High - Low
79.69 - 75.00
52W High-Low
93.90 - 32.85
ann
Q3 Quarterly Results are out. Check out the updated financials2 days ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
153.36 Cr
EPS
0.52
PE Ratio
148.23
PB Ratio
2.13
Book Value
36.12
EBITDA
9.80
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
0.12
Debt to Equity
0.35
Forecast For
Actual

Company News

View All News
Caret
positive
Jeevan Scientific Technology reported a consolidated net profit of ₹103.33 lakh for FY26, a 1651% increase from ₹5.90 lakh in FY25. Revenue from operations rose to ₹6,153.71 lakh.
neutral
Jeevan Scientific Technology Limited board will meet on May 29, 2026, to consider audited financial statements for Q4 and FY26.
neutral
Jeevan Scientific Technology Limited submits compliance certificate under SEBI Regulation 74(5) for quarter ended March 31, 2026, confirming no dematerialization requests received during the period.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
439.90
#1 17,725.31
57.01
#1 3,738.70
0.66
324
-19.31
47.57
512.80
12,348.63
#1 30.60
3,510.50
19.14
#1 349
-32.23
49.51
274.10
7,228.58
-26.22
7.11
-59.60
-276
-3.87
71.62
457.65
2,044.29
35.09
322.30
0.22
41
112.87
50.07
30.70
454.16
42.27
54.19
#1 431.27
11
189.80
40.28
65.99
155.37
-3.64
733.54
-9.05
-21
-35.54
67.12
77.01
#7 153.36
#6 148.23
#5 61.54
#2 29.56
#5 2
#1 238.46
42.73
18.41
26.60
33.09
56.10
-33.21
1
-88.00
23.58
22.07
15.68
-1.24
2.10
-78.57
-13
-333.33
61.53
Growth Rate
Revenue Growth
29.56 %
Net Income Growth
1,880.00 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
-7.66 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
3
0
9
5
4
5
4
5
6
5
5
6
5
6
8
8
4
3
6
9
9
5
13
16
16
16
19
21
17
11
8
10
8
11
8
10
11
13
12
13
10
9
13
19
22
Expenses
3
0
7
4
4
4
3
4
4
5
4
5
4
5
6
6
5
5
6
6
14
5
7
8
11
10
12
14
14
9
8
9
9
8
8
9
10
10
9
10
10
11
10
14
17
EBITDA
1
0
2
1
-1
1
1
1
1
1
1
2
1
2
3
3
-1
-1
0
2
-5
1
6
9
5
6
7
7
3
2
-0
2
-1
2
1
1
1
3
3
2
-0
-1
2
5
5
Operating Profit %
20 %
0 %
16 %
19 %
-17 %
16 %
17 %
17 %
16 %
9 %
21 %
21 %
13 %
22 %
29 %
32 %
-15 %
-42 %
-6 %
23 %
-95 %
15 %
38 %
53 %
32 %
36 %
34 %
32 %
-18 %
12 %
-5 %
15 %
-13 %
20 %
7 %
10 %
9 %
25 %
22 %
17 %
-4 %
-20 %
17 %
27 %
20 %
Depreciation
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
2
2
2
2
2
2
2
2
2
Interest
0
0
1
0
0
0
0
0
0
0
1
1
0
0
1
1
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
Profit Before Tax
0
0
1
0
-1
0
0
0
1
0
0
0
0
1
1
1
-2
-3
-2
1
-7
-1
4
7
4
5
5
6
2
0
-2
0
-3
1
-1
-1
-1
2
1
0
-3
-4
0
3
3
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
-0
-1
-0
0
-1
-0
1
1
0
1
2
2
2
-0
-0
0
-0
0
-0
-0
0
1
1
0
-1
-1
0
1
1
Net Profit
0
0
1
0
-1
0
0
0
1
0
0
0
-0
0
1
1
-2
-2
-1
0
-6
-1
3
6
4
3
4
4
1
0
-1
0
-2
1
-1
-1
-1
1
0
0
-1
-3
0
2
2
EPS in ₹
0.70
0.00
1.50
0.25
-1.77
0.16
0.20
0.24
0.51
0.03
0.09
0.12
-0.05
0.26
0.93
0.52
-0.97
-1.37
-0.95
0.26
-3.56
-0.37
1.79
3.74
2.56
2.17
2.45
2.80
0.52
0.25
-0.78
0.04
-1.51
0.33
-0.39
-0.31
-0.47
0.66
0.16
0.03
-0.81
-2.03
0.01
1.52
0.92

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
20
31
49
61
54
66
78
66
68
78
107
Fixed Assets
9
16
28
33
31
27
19
25
27
35
41
Current Assets
11
14
21
25
18
34
54
29
25
29
50
Capital Work in Progress
0
0
0
0
0
0
0
2
3
5
5
Investments
0
0
0
0
0
0
0
0
0
0
3
Other Assets
12
15
21
29
23
39
59
39
38
39
0
Total Equity & Liabilities
20
31
49
61
54
66
78
66
68
78
107
Current Liabilities
8
9
17
21
23
23
22
11
9
12
20
Non Current Liabilities
8
5
10
8
8
8
5
6
10
16
14
Total Equity
4
17
22
32
23
35
51
48
49
50
72
Reserve & Surplus
-2
3
7
17
8
20
35
33
33
34
52
Share Capital
6
9
12
15
15
15
15
16
16
16
20

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
2
-2
4
24
-23
-6
-0
Investing Activities
-4
-9
-14
-8
-2
-1
-1
-7
-12
-16
Operating Activities
4
-6
6
4
0
5
20
-6
3
10
Financing Activities
0
15
10
6
0
-0
6
-10
2
5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
38.11 %
38.11 %
38.11 %
38.11 %
36.15 %
36.47 %
36.47 %
36.85 %
38.44 %
38.48 %
38.48 %
38.48 %
38.70 %
38.70 %
38.70 %
37.84 %
38.05 %
38.05 %
38.05 %
38.05 %
30.25 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
48.08 %
45.99 %
46.82 %
46.70 %
48.56 %
48.38 %
44.89 %
44.65 %
42.87 %
42.89 %
45.98 %
45.51 %
45.50 %
45.34 %
45.75 %
45.91 %
42.99 %
42.75 %
42.76 %
46.56 %
55.79 %
Others
13.81 %
15.90 %
15.06 %
15.18 %
15.29 %
15.15 %
18.64 %
18.50 %
18.69 %
18.63 %
15.53 %
16.00 %
15.80 %
15.96 %
15.55 %
16.25 %
18.96 %
19.21 %
19.19 %
15.39 %
13.96 %
No of Share Holders
2,740
3,999
5,499
5,813
6,144
6,439
6,449
6,295
6,061
5,911
5,933
5,727
5,749
5,655
5,607
5,565
5,497
5,460
5,444
5,159
5,053

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.5 1.2 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.38 2.38 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
08 Sept 2021 DIVIDEND Dividend
0.50 /share
07 Sept 2021 98.10 96.40
23 Sept 2022 DIVIDEND Dividend
1.20 /share
21 Sept 2022 83.05 66.35
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Aug 2024 50.73 56.59
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 52.94 52.88
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 45.04 45.23
27 Mar 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
27 Mar 2025 43.01 41.38
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 41.03 40.32
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 39.36 42.31
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 38.41 35.00
12 Nov 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2025 55.77 60.05
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 62.83 60.05
11 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2026 69.25 69.25
29 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2026 82.80 84.36

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance3 days ago
Statement Of Deviation Or Variation Of Funds3 days ago
Announcement under Regulation 30 (LODR)-Change in Management3 days ago
Audited Financial Results For The Quarter And Year Ended 31.03.20263 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 29.05.20263 days ago
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 29-05-2026May 21, 2026
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 30, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 30, 2026
Closure of Trading WindowMar 25, 2026
Unaudited Financial Results For The Quarter Ended 31-12-2025.Feb 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 11-02-2026Feb 11, 2026
Closure Of The United States Food And Drug Administration (US FDA) Remote Regulatory Assessment Of JSTL And Issuance Of The Remote Regulatory Assessment Report - Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Jan 22, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 07, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 07, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 06, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 02.01.2026Jan 02, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 31, 2025
Update on board meetingDec 29, 2025
Closure of Trading WindowDec 26, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30-12-2025.Dec 24, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 18, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationNov 12, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 12, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMNov 12, 2025
Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025Nov 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025Nov 12, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12.11.2025Nov 07, 2025
Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 About The Completion Of US FDA Remote Interactive Evaluation (RIE) Of JSTL.Nov 07, 2025
Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through Video Conference / Other Audio-Visual Means (VC/OAVM)Oct 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Announcement under Regulation 30 (LODR)-Preferential IssueOct 15, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 15.10.2025Oct 15, 2025
Board Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising ProposalOct 10, 2025
Announcement under Regulation 30 (LODR)-RetirementOct 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025

Technical Indicators

RSI(14)
Neutral
41.80
ATR(14)
Volatile
5.41
STOCH(9,6)
Neutral
32.10
STOCH RSI(14)
Oversold
11.70
MACD(12,26)
Bearish
-1.04
ADX(14)
Weak Trend
24.51
UO(9)
Bearish
35.75
ROC(12)
Downtrend And Accelerating
-8.85
WillR(14)
Oversold
-95.61